Stock

BIOCON

Biocon Limited
Health Technology

Daily Margin Trading Facility book for BIOCON across NSE and BSE, from 01 Jan 2025. All figures in ₹ crore, derived from exchange public disclosures.

Funded value
₹123 Cr
as of 10 Sep 2026
Rank in book
#315
407 days tracked
Share of book
0.08%
of the whole NSE + BSE book
Peak funded
₹164 Cr
on 02 Feb 2026
Largest single-day addition
+₹28 Cr
on 14 Jan 2026
Largest single-day unwind
−₹37 Cr
on 03 Feb 2026

NSE & BSE split

How BIOCON’s funded book divides across the two exchanges, as of 10 Sep 2026.
NSE
NSE ₹118 Cr · 95.9%BSE ₹5 Cr · 4.1%

MTF vs Price

Margin-funded outstanding for BIOCON in ₹ crore against the closing price, adjusted for splits and bonuses. Each window uses the same reference date as the table below, so the two agree. Funded value moves with the price on its own, so the line under the chart reads the share count instead — that is what shows whether more stock is genuinely being borrowed against.
MTF book (₹ Cr)

Price and liquidity

Adjusted for splits and bonuses, so a change across a corporate action reflects the market rather than the share count.
Last close
₹390.65
as of 11 Sep 2026
Price, 30 days
−8.2%
adjusted for splits and bonuses
Delivery, 20-day avg
52.1%
of traded volume actually settled
Sessions to unwind
2.0
of average deliverable volume
Shares under margin divided by average daily deliverable volume over the last 20 sessions.

Book, shares and price by window

Funded value moves with the price on its own, so the share count is what shows whether more stock is actually being borrowed against. The last column reads the two together.
WindowBook ΔBook %SharesPriceReading
1 day+₹5+3.9%+4.1%
+1,17,848
−0.8%building as it falls
10 days+₹26+26.1%+27.9%
+6,51,781
−6.4%building as it falls
30 days+₹47+61.6%+64.4%
+11,70,946
−7.9%building as it falls
90 days+₹60+96.0%+94.7%
+14,53,714
−6.5%building as it falls
180 days+₹12+10.8%+4.1%
+1,16,522
+0.5%building into strength
1 year+₹12+10.6%−7.8%
−2,51,536
+7.5%unwinding into strength
Price is as of 11 Sep 2026; the MTF book is as of 10 Sep 2026. Exchanges publish the margin file a day after the market data, and the comparison above uses the MTF date for both sides.

Shares under margin

Number of shares funded via MTF over time (NSE + BSE combined).

Rank trajectory

Where BIOCON has sat in the funded-value ranking each day (1 = most funded). Lower is more prominent.

BIOCON — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole book, and rank. Newest first.
DateCombined (₹ Cr)Day Δ (₹ Cr)% of bookRank
10 Sep 2026123+₹50.08%315
09 Sep 2026119+₹80.08%326
08 Sep 2026111+₹20.07%347
07 Sep 2026109+₹20.07%352
04 Sep 2026107+₹20.07%352
03 Sep 2026105+₹20.07%355
02 Sep 2026103+₹00.07%361
01 Sep 2026103+₹30.07%364
31 Aug 2026100+₹10.07%369
28 Aug 202699+₹10.07%373
27 Aug 202698−₹20.06%379
26 Aug 2026100−₹00.07%366
25 Aug 2026100−₹10.07%364
24 Aug 2026102+₹30.07%364
21 Aug 202698+₹10.07%374
20 Aug 202698+₹10.07%373
19 Aug 202696+₹00.07%380
18 Aug 202696−₹00.07%379
17 Aug 202697+₹30.07%373
14 Aug 202694+₹20.06%385
13 Aug 202692+₹30.06%395
12 Aug 202688+₹20.06%405
11 Aug 202687−₹00.06%416
10 Aug 202687+₹00.06%414
07 Aug 202687+₹40.06%415
06 Aug 202683−₹40.06%430
05 Aug 202687+₹50.06%414
04 Aug 202682+₹40.06%421
03 Aug 202679+₹20.06%437
31 Jul 2026760.05%448

BIOCON within Health Technology

Ranked #16 of 61 funded Health Technology stocks, carrying 1.9% of that sector’s margin book. Nearest names by funded value:
#StockMTF book (₹ Cr)% of sector
14SHILPAMED
Shilpa Medicare Limited
₹1402.2%
15GRANULES
Granules India Limited
₹1272.0%
16BIOCON
Biocon Limited
₹1231.9%
17PPLPHARMA
Piramal Pharma Limited
₹1131.8%
18LENSKART
Lenskart Solutions Limited
₹1011.6%

All Health Technology stocks and how the sector has moved →

Disclaimer. Data sourced from daily margin trading disclosure provided by NSE and BSE. This website and page are meant for educational and information only — not investment advice. MTF is leveraged and can amplify losses. Rules, margins, rates and eligible-stock lists change; verify current details with your broker and SEBI/exchange circulars. IndiaMTF.com is not a SEBI-registered intermediary, broker, or investment adviser and has no affiliation with SEBI, NSE or BSE. Figures are reproduced from publicly disclosed exchange data, may be delayed or revised, and should be independently verified before any trading decision. Consult a SEBI-registered investment adviser before investing.